TOI
The Oncology Institute Breaks New Ground in Q4 2025: Strong Revenue Growth, First Profitable Quarter, and Expansion Plans
The Oncology Institute (TOI) has announced its fourth-quarter results for 2025, marking a significant milestone for the company. In a conference call on March 12, 2026, TOI's leadership shared their insights into the quarter's performance, highlighting key achievements and future plans. According to Daniel Virnich, CEO